Increased fluoroquinolone resistance with time in from 17,000 patients at a large county hospital as a function of culture site, age, sex, and location-3

<p><b>Copyright information:</b></p><p>Taken from "Increased fluoroquinolone resistance with time in from >17,000 patients at a large county hospital as a function of culture site, age, sex, and location"</p><p>http://www.biomedcentral.com/1471-2334/8/4</p><p>BMC Infectious Diseases 2008;8():4-4.</p><p>Published online 15 Jan 2008</p><p>PMCID:PMC2258293.</p><p></p>loxacin; and OFX, ofloxacin. For these and subsequent graphs, the number of isolates in each category is shown above each bar. The frequency of resistance increased significantly by Chi-square tests (≤ 0.01) each year except from 1999 to 2000 and 2001 to 2002. (A) Average percentage of non-susceptible isolates from 1999 to 2004 for each fluoroquinolone. Resistant ("R") and intermediate ("I") isolates for each fluoroquinolone are shown. With regards to statistical significance, levofloxacin and ofloxacin resistance was the same by Chi-square analysis, and both were distinct from ciprofloxacin, gatifloxacin, and norfloxacin. (B) Total fluoroquinolone non-susceptibility over time. The average percentage of "R" and "I" isolates for all the tested fluoroquinolones combined for each year is shown. (C) Percentage of non-susceptible isolates for each fluoroquinolone in 2002

Increased fluoroquinolone resistance with time in from 17,000 patients at a large county hospital as a function of culture site, age, sex, and location-2

<p><b>Copyright information:</b></p><p>Taken from "Increased fluoroquinolone resistance with time in from >17,000 patients at a large county hospital as a function of culture site, age, sex, and location"</p><p>http://www.biomedcentral.com/1471-2334/8/4</p><p>BMC Infectious Diseases 2008;8():4-4.</p><p>Published online 15 Jan 2008</p><p>PMCID:PMC2258293.</p><p></p> isolates is shown for female and male patients. (B) Fluoroquinolone resistance in female and male patients as a function of location. Because so few fluoroquinolone-resistant genital isolates existed, these data were excluded from analysis. (C) Fluoroquinolone resistance in female and male patients as a function of culture site

Increased fluoroquinolone resistance with time in from 17,000 patients at a large county hospital as a function of culture site, age, sex, and location-1

<p><b>Copyright information:</b></p><p>Taken from "Increased fluoroquinolone resistance with time in from >17,000 patients at a large county hospital as a function of culture site, age, sex, and location"</p><p>http://www.biomedcentral.com/1471-2334/8/4</p><p>BMC Infectious Diseases 2008;8():4-4.</p><p>Published online 15 Jan 2008</p><p>PMCID:PMC2258293.</p><p></p>-square tests. With regards to statistical significance, overall, fluoroquinolone resistance increased with patient age

Increased fluoroquinolone resistance with time in from 17,000 patients at a large county hospital as a function of culture site, age, sex, and location-0

<p><b>Copyright information:</b></p><p>Taken from "Increased fluoroquinolone resistance with time in from >17,000 patients at a large county hospital as a function of culture site, age, sex, and location"</p><p>http://www.biomedcentral.com/1471-2334/8/4</p><p>BMC Infectious Diseases 2008;8():4-4.</p><p>Published online 15 Jan 2008</p><p>PMCID:PMC2258293.</p><p></p>loxacin; and OFX, ofloxacin. For these and subsequent graphs, the number of isolates in each category is shown above each bar. The frequency of resistance increased significantly by Chi-square tests (≤ 0.01) each year except from 1999 to 2000 and 2001 to 2002. (A) Average percentage of non-susceptible isolates from 1999 to 2004 for each fluoroquinolone. Resistant ("R") and intermediate ("I") isolates for each fluoroquinolone are shown. With regards to statistical significance, levofloxacin and ofloxacin resistance was the same by Chi-square analysis, and both were distinct from ciprofloxacin, gatifloxacin, and norfloxacin. (B) Total fluoroquinolone non-susceptibility over time. The average percentage of "R" and "I" isolates for all the tested fluoroquinolones combined for each year is shown. (C) Percentage of non-susceptible isolates for each fluoroquinolone in 2002